共 195 条
- [1] Renkonen-Sinisalo L(2006)Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome Int J Cancer 120 821-824
- [2] Butzow R(2005)Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment J Med Genet 42 491-496
- [3] Leminen A(2007)Society of Gynecologic Oncologists Education Committee. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions Gynecol Oncol 107 159-162
- [4] Lehtovirta P(2008)The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations Gastroenterology 135 419-428
- [5] Mecklin JP(2010)Risks of Lynch syndrome cancers for MSH6 mutation carriers J Natl Cancer Inst 102 193-201
- [6] Jarvinen HJ(2015)The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome Fam Cancer 14 51-60
- [7] Quehenberger F(2009)Management of extra-colonic tumours in patients with Lynch syndrome Lancet Oncol 10 400-408
- [8] Vasen HF(2010)Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma Int J Cancer 127 2678-2684
- [9] Van Houwelingen HC(2015)The gynecological surveillance of women with Lynch syndrome in Sweden Gynecol Oncol 138 717-722
- [10] Lancaster JM(2013)Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts Gut 62 812-823